Influenza Vaccination Market Stance By Growth, Size, Share, Trends, and Manufacturers
Research Reports
Jan 05, 2021
Market Analysis
The global influenza vaccination market is likely to touch USD 7,828.3 million at a 6.53% CAGR between 2019- 2025, according to the recent Market Research Future (MRFR) report. Influenza or flu, simply put, is a contagious respiratory infection that results from influenza viruses. The different types of influenza viruses comprise type D, C, B, and A. It is type A & B that is the most common type responsible for seasonal flu every year. This virus enters into a person’s respiratory system and is transmitted to others through inhalation of virus-laden aerosols or direct contact. The best way of preventing this influenza is through vaccination. Quadrivalent vaccines and trivalent vaccines are the two different types of influenza vaccines.
Request Sample Copy:
https://www.marketresearchfuture.com/sample_request/1621
Some of the common symptoms include feeling tired, joint pains, sore throat, coughing, headache, running nose, high fever, and sneezing. Besides, vomiting and diarrhea are additional symptoms that are observed in children. Newer versions of vaccines are made twice a year for the rapid changes in this virus. Its effectiveness varies from year to year, yet is known in offering high to moderate protection against influenza.
Various factors are adding to the global influenza vaccination market growth. These factors, according to the latest MRFR report, include increasing funds and investments by companies in research and development activities, development of new vaccines, advances in existing vaccines, minimal side effects related to influenza vaccines, and increasing initiatives by the government for ensuring the well-being of the population.
Market Segmentation
The MRFR report offers an inclusive segmental analysis of the global influenza vaccination market based on end user, vaccine type, manufacturing technology, and type.
By type, the global influenza vaccination market is segmented into zoonotic and seasonal.
By manufacturing technology, the global influenza vaccination market is segmented into recombinant-based, cell culture-based, and egg-based.
By vaccine type, the global influenza vaccination market is segmented into quadrivalent vaccines and trivalent vaccines.
By end user, the global influenza vaccination market is segmented into academic institutions, research organizations, hospitals and clinics, and others.
Regional Analysis
Based on the region, the global influenza vaccination market covers the recent trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), & the Middle East & Africa (MEA). Of these, the Americas will have the lions share in the market over the forecast period for the increasing cases of influenza.
The global influenza vaccination market in Europe is predicted to have the second-largest share over the forecast period for the increase in product launches and the rising prevalence of seasonal influenza. Besides, the rising demand for influenza vaccines is also adding market growth.
The global influenza vaccination market in the APAC region is predicted to grow at a fast pace during the forecast period due to the increasing investment by top companies for enhancing their foothold in the market.
The global influenza vaccination market in the MEA is likely to have the smallest share over the forecast period for the limited availability and access to treatment facilities. Meanwhile, the constantly increasing demand for vaccination and developing healthcare infrastructure are also adding market growth.
Key Players
Eminent players profiled in the global influenza vaccination market report include Mylan NV (US), Serum Institute of India Pvt. Ltd (India), Mitsubishi Tanabe Pharma (Japan), Abbott Laboratories (US), Sanofi (France), GlaxoSmithKline PLC (UK), and AstraZeneca (UK). Industry players have incorporated strategies such as acquisitions and mergers, new product launch, strategic alliances, R&D activities for creating a niche in the market.
Browse Full Report @
https://www.marketresearchfuture.com/reports/influenza-vaccination-market-1621
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Tags:
, Reportedtimes, iCN Internal Distribution, Research Newswire, English
YOU MAY ALSO LIKE
PW Consulting Releases Comprehensive Market Research on…
Market Analysis The global influenza vaccination market is likely to touch USD 7,828.3 million at a 6.53% CAGR between 2019- 2025, according to the recent…
read more